Diabetes Metab J 2013;37:429-432 Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR

Kuecker CM
Vivian EM

February 2016

Catherine M Kuecker, Eva M Vivian Pharmacy Practice Division, School of Pharmacy, University of Wisc...

Empagliflozin and metformin combination therapy in Type 2 diabetes mellitus

Jeyalalitha, R.

January 2017

Diabetes mellitus (DM) is a spectrum of metabolic disorder characterized by chronic hyperglycemia ei...

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

Shannon A Miller
Erin L St Onge
J Roger Accardi

May 2009

Shannon A Miller1, Erin L St Onge2, J Roger Accardi31Pharmacotherapy Faculty, Florida Hospital East ...

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Young Ki Lee
Sun Ok Song
Kwang Joon Kim
Yongin Cho
Younjeong Choi
Yujung Yun
Byung-wan Lee
Eun-seok Kang
Bong Soo Cha
Hyun Chul Lee

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Combination for the Treatment of Type 2 Diabetes Mellitus

Chitrabhanu Ballav
Stephen C. L. Gough

November 2015

This is an open access article published under the Creative Commons CC-BY-NC 3.0 license

Diabetes Metab J 2014;38:261-273 A Novel Therapeutic Agent for Type 2 Diabetes

Mellitus Sglt Inhibitor
Chang Hee Jung
Jung Eun Jang
Joong-yeol Park

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Hayes J
Anderson R
Stephens JW

July 2016

Jennifer Hayes,1 Rosie Anderson,1 Jeffrey W Stephens1,2 1Department of Diabetes and Endocrinology, ...

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

Fleming JW
Fleming LW
Davis CS

June 2015

Joshua W Fleming, Laurie W Fleming, Courtney S Davis Department of Pharmacy Practice, The University...

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes

Green J
Karen K
Cox ME

October 2010

Karen Barnard1,2, Mary Elizabeth Cox1, Jennifer B Green1,21Department of Medicine, Division of Endoc...

Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus

A. M. Mkrtumyan

March 2018

Many anti-diabetic drugs are now available to treat type 2 diabetes mellitus, including sulfonylurea...

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes

Singh AK
Singh R
Chakraborty PP

July 2021

Awadhesh K Singh,1 Ritu Singh,1 Partha Pratim Chakraborty2 1Department of Diabetes & Endocrinology, ...

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Schwartz SS
Katz A

March 2016

Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Hea...

Diabetes Metab J 2013;37:212-213 Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes

Single-arm Study (diabetes Metab J
Byung-wan Lee

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

New combination treatments in the management of diabetes: focus on sitagliptin – metformin

Jennifer Green
Mark Feinglos

August 2008

Jennifer Green, Mark FeinglosDuke University Medical Center, Department of Medicine, Division of End...

Diabetes Metab J 2015;39:171-172 Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes

Metab J
Hannah Seok
Corresponding Hannah Seok

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR

Kuecker CM
Vivian EM

February 2016

Catherine M Kuecker, Eva M Vivian Pharmacy Practice Division, School of Pharmacy, University of Wisc...

Empagliflozin and metformin combination therapy in Type 2 diabetes mellitus

Jeyalalitha, R.

January 2017

Diabetes mellitus (DM) is a spectrum of metabolic disorder characterized by chronic hyperglycemia ei...

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

Shannon A Miller
Erin L St Onge
J Roger Accardi

May 2009

Shannon A Miller1, Erin L St Onge2, J Roger Accardi31Pharmacotherapy Faculty, Florida Hospital East ...

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Young Ki Lee
Sun Ok Song
Kwang Joon Kim
Yongin Cho
Younjeong Choi
Yujung Yun
Byung-wan Lee
Eun-seok Kang
Bong Soo Cha
Hyun Chul Lee

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Combination for the Treatment of Type 2 Diabetes Mellitus

Chitrabhanu Ballav
Stephen C. L. Gough

November 2015

This is an open access article published under the Creative Commons CC-BY-NC 3.0 license

Diabetes Metab J 2014;38:261-273 A Novel Therapeutic Agent for Type 2 Diabetes

Mellitus Sglt Inhibitor
Chang Hee Jung
Jung Eun Jang
Joong-yeol Park

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Hayes J
Anderson R
Stephens JW

July 2016

Jennifer Hayes,1 Rosie Anderson,1 Jeffrey W Stephens1,2 1Department of Diabetes and Endocrinology, ...

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

Fleming JW
Fleming LW
Davis CS

June 2015

Joshua W Fleming, Laurie W Fleming, Courtney S Davis Department of Pharmacy Practice, The University...

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes

Green J
Karen K
Cox ME

October 2010

Karen Barnard1,2, Mary Elizabeth Cox1, Jennifer B Green1,21Department of Medicine, Division of Endoc...

Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus

A. M. Mkrtumyan

March 2018

Many anti-diabetic drugs are now available to treat type 2 diabetes mellitus, including sulfonylurea...

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes

Singh AK
Singh R
Chakraborty PP

July 2021

Awadhesh K Singh,1 Ritu Singh,1 Partha Pratim Chakraborty2 1Department of Diabetes & Endocrinology, ...

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Schwartz SS
Katz A

March 2016

Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Hea...

Diabetes Metab J 2013;37:212-213 Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes

Single-arm Study (diabetes Metab J
Byung-wan Lee

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

New combination treatments in the management of diabetes: focus on sitagliptin – metformin

Jennifer Green
Mark Feinglos

August 2008

Jennifer Green, Mark FeinglosDuke University Medical Center, Department of Medicine, Division of End...

Diabetes Metab J 2015;39:171-172 Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes

Metab J
Hannah Seok
Corresponding Hannah Seok

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR

Kuecker CM
Vivian EM

February 2016

Catherine M Kuecker, Eva M Vivian Pharmacy Practice Division, School of Pharmacy, University of Wisc...

Empagliflozin and metformin combination therapy in Type 2 diabetes mellitus

Jeyalalitha, R.

January 2017

Diabetes mellitus (DM) is a spectrum of metabolic disorder characterized by chronic hyperglycemia ei...

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

Shannon A Miller
Erin L St Onge
J Roger Accardi

May 2009

Shannon A Miller1, Erin L St Onge2, J Roger Accardi31Pharmacotherapy Faculty, Florida Hospital East ...

Diabetes Metab J 2013;37:429-432 Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients

Abstract

Extracted data

Diabetes Metab J 2013;37:429-432 Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients

Abstract

Extracted data

Related items

Related items